Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Follow up results of a prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Esophageal cancer
10.1016/0360-3016(83)90329-2 · 1983 · External reference
Cancers of the gastrointestinal tract
1998 · External reference
Mediastinal staging of non-small-cell lung cancer with positron emission tomography
10.1164/ajrccm.152.6.8520780 · 1995 · External reference
Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation
10.1148/radiology.191.2.8153308 · 1994 · External reference
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma
10.1200/jco.2000.18.18.3202 · 2000 · External reference
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging
10.1200/jco.2001.19.12.3058 · 2001 · External reference
Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy
10.1016/s0360-3016(02)02705-0 · 2002 · External reference
Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma
10.1002/cncr.10330 · 2002 · External reference
Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study
10.1200/jco.2001.19.1.111 · 2001 · External reference
FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological features
10.1097/00006231-200008000-00002 · 2000 · External reference
Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer
10.1093/annonc/mdf081 · 2002 · External reference
PET in lung cancer
1999 · External reference
Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography
10.1097/00000658-200103000-00002 · 2001 · External reference
The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma
10.1002/(sici)1097-0142(19980901)83:5<918::aid-cncr17>3.0.co;2-y · 1998 · External reference
A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer
10.1016/j.radonc.2006.02.014 · 2006 · External reference
Value of functional imaging by PET in esophageal cancer
10.6004/jnccn.2015.0030 · 2015 · External reference
Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer
10.1007/s00259-005-0028-8 · 2006 · External reference
PET-CT offers accurate assessment of tumour length in oesophageal malignancy
10.1016/j.ejrad.2014.10.014 · 2015 · External reference
The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma
10.1016/j.ijrobp.2004.07.717 · 2005 · External reference
Validation of a 4D-PET maximum intensity projection for delineation of an internal target volume
10.1016/j.ijrobp.2013.02.030 · 2013 · External reference
Clinical validation of FDG-PET/CT in the radiation treatment planning for patients with oesophageal cancer
10.1016/j.radonc.2014.10.016 · 2014 · External reference
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85–01)
1999 · External reference
INT 0123 (Radiation Therapy Oncology Group 94–05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy
10.1200/jco.2002.20.5.1167 · 2002 · External reference
Longitudinal quality-of-life analysis of RTOG 94–05 (Int 0123): a phase III trial of definitive chemoradiotherapy for esophageal cancer
2011 · External reference
A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92–07): preliminary toxicity report
10.1016/s0360-3016(96)00591-3 · 1997 · External reference